Literature DB >> 26144659

Expression and functionality of Toll- and RIG-like receptors in HepaRG cells.

Souphalone Luangsay1, Malika Ait-Goughoulte1, Maud Michelet2, Océane Floriot2, Marc Bonnin2, Marion Gruffaz2, Michel Rivoire3, Simon Fletcher4, Hassan Javanbakht4, Julie Lucifora2, Fabien Zoulim5, David Durantel6.   

Abstract

BACKGROUND & AIMS: HepaRG cells are considered as the best surrogate model to primary human hepatocyte (PHH) culture to investigate host-pathogen interactions. Yet their innate immune functions remain unknown. In this study, we explored the expression and functionality of Toll-like (TLR) and retinoic acid-inducible gene-1 (RIG-I)-like receptors (RLR) in these cells.
METHODS: Gene and protein expression levels of TLR-1 to 9 and RLR in HepaRG were mainly compared to PHH, by RT-qPCR, FACS, and Western blotting. Their functionality was assessed, by measuring the induction of toll/rig-like themselves and several target innate gene expressions, as well as the secretion of IL-6, IP-10, and type I interferon (IFN), upon agonist stimulation. Their functionality was also shown by measuring the antiviral activity of some TLR/RLR agonists against hepatitis B virus (HBV) infection.
RESULTS: The basal gene and protein expression profile of TLR/RLR in HepaRG cells was similar to PHH. Most receptors, except for TLR-7 and 9, were expressed as proteins and functionally active as shown by the induction of some innate genes, as well as by the secretion of IL-6 and IP-10, upon agonist stimulation. The highest levels of IL-6 and IP-10 secretion were obtained by TLR-2 and TLR-3 agonist stimulation respectively. The highest preventive anti-HBV activity was obtained following TLR-2, TLR-4 or RIG-I/MDA-5 stimulations, which correlated with their high capacity to produce both cytokines.
CONCLUSIONS: Our results indicate that HepaRG cells express a similar pattern of functional TLR/RLR as compared to PHH, thus qualifying HepaRG cells as a surrogate model to study pathogen interactions within a hepatocyte innate system.
Copyright © 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antiviral activity; Hepatitis B virus; Hepatocyte; Pathogen recognition receptor; Toll-like receptor

Mesh:

Substances:

Year:  2015        PMID: 26144659     DOI: 10.1016/j.jhep.2015.06.022

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  24 in total

Review 1.  Global strategies are required to cure and eliminate HBV infection.

Authors:  Peter Revill; Barbara Testoni; Stephen Locarnini; Fabien Zoulim
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

2.  Interaction between Toll-Like Receptor 9-CpG Oligodeoxynucleotides and Hepatitis B Virus Virions Leads to Entry Inhibition in Hepatocytes and Reduction of Alpha Interferon Production by Plasmacytoid Dendritic Cells.

Authors:  Ludovic Aillot; Marc Bonnin; Malika Ait-Goughoulte; Nathalie Bendriss-Vermare; Sarah Maadadi; Laura Dimier; Miroslava Subic; Caroline Scholtes; Isabel Najera; Fabien Zoulim; Julie Lucifora; David Durantel
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 3.  Treatment of chronic hepatitis B with pattern recognition receptor agonists: Current status and potential for a cure.

Authors:  Jinhong Chang; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2015-07-20       Impact factor: 5.970

4.  Molecular cloning, characterization and expression analysis of woodchuck retinoic acid-inducible gene I.

Authors:  Qi Yan; Qin Liu; Meng-Meng Li; Fang-Hui Li; Bin Zhu; Jun-Zhong Wang; Yin-Ping Lu; Jia Liu; Jun Wu; Xin Zheng; Meng-Ji Lu; Bao-Ju Wang; Dong-Liang Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

Review 5.  Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses: Experimental Models and Molecular Mechanisms.

Authors:  Emmanuel Thomas; Thomas F Baumert
Journal:  Semin Liver Dis       Date:  2019-07-02       Impact factor: 6.512

Review 6.  Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.

Authors:  Suzanne Faure-Dupuy; Julie Lucifora; David Durantel
Journal:  Viruses       Date:  2017-04-28       Impact factor: 5.048

Review 7.  Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.

Authors:  Zhiyong Ma; Qian Cao; Yong Xiong; Ejuan Zhang; Mengji Lu
Journal:  Vaccines (Basel)       Date:  2018-01-16

8.  Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes.

Authors:  Julie Lucifora; Marc Bonnin; Ludovic Aillot; Floriane Fusil; Sarah Maadadi; Laura Dimier; Maud Michelet; Océane Floriot; Anaïs Ollivier; Michel Rivoire; Malika Ait-Goughoulte; Stéphane Daffis; Simon P Fletcher; Anna Salvetti; François-Loïc Cosset; Fabien Zoulim; David Durantel
Journal:  Sci Rep       Date:  2018-03-29       Impact factor: 4.379

9.  NOD1 Participates in the Innate Immune Response Triggered by Hepatitis C Virus Polymerase.

Authors:  Serena Vegna; Damien Gregoire; Marie Moreau; Patrice Lassus; David Durantel; Eric Assenat; Urszula Hibner; Yannick Simonin
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

Review 10.  Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability.

Authors:  Marina Campos-Valdez; Hugo C Monroy-Ramírez; Juan Armendáriz-Borunda; Laura V Sánchez-Orozco
Journal:  Viruses       Date:  2021-06-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.